Sale!

KCNB1 Gene Early infantile epileptic encephalopathy type 26 Genetic Test

4,400 د.إ

-21%

The KCNB1 gene plays a crucial role in the proper functioning of the nervous system, and mutations in this gene are associated with early infantile epileptic encephalopathy type 26 (EIEE26). This condition is characterized by frequent seizures that begin in infancy, along with various degrees of developmental delay and sometimes additional neurological symptoms. Given the significant impact this condition can have on affected individuals and their families, genetic testing for mutations in the KCNB1 gene is an important diagnostic tool.

DNA Labs UAE offers a specialized genetic test aimed at identifying mutations within the KCNB1 gene to confirm a diagnosis of early infantile epileptic encephalopathy type 26. This test is crucial for affected families, as it not only aids in the diagnosis but also helps in guiding treatment decisions and understanding the prognosis. Furthermore, it can provide valuable information for genetic counseling, particularly for family planning and assessing the risk of recurrence in future pregnancies.

The test cost is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to accurately interpret the results. Conducted in a state-of-the-art laboratory by professionals skilled in genetic diagnostics, this test represents a significant step forward for families seeking answers in the face of challenging neurological conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNB1 Gene Early infantile epileptic encephalopathy type 26 Genetic Test

Test Details

The KCNB1 gene is associated with early infantile epileptic encephalopathy type 26 (EIEE26), a rare genetic disorder characterized by seizures that begin in infancy and developmental delays.

NGS (Next Generation Sequencing) genetic testing can be used to identify mutations in the KCNB1 gene that may be causing EIEE26. This test involves analyzing the patient’s DNA to identify any changes or mutations in the KCNB1 gene.

Identifying the specific mutation in the KCNB1 gene can help with diagnosis and management of EIEE26. Treatment for EIEE26 typically involves antiepileptic medications and supportive therapies to manage symptoms and improve quality of life.

Test Name: KCNB1 Gene Early infantile epileptic encephalopathy type 26 Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for KCNB1 Gene Early infantile epileptic encephalopathy type 26 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with KCNB1 Gene Early infantile epileptic encephalopathy type 26

Test Name KCNB1 Gene Early infantile epileptic encephalopathy type 26 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNB1 Gene Early infantile epileptic encephalopathy type 26 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNB1 Gene Early infantile epileptic encephalopathy type 26
Test Details

The KCNB1 gene is associated with early infantile epileptic encephalopathy type 26 (EIEE26), a rare genetic disorder characterized by seizures that begin in infancy and developmental delays.

NGS (Next Generation Sequencing) genetic testing can be used to identify mutations in the KCNB1 gene that may be causing EIEE26. This test involves analyzing the patient’s DNA to identify any changes or mutations in the KCNB1 gene.

Identifying the specific mutation in the KCNB1 gene can help with diagnosis and management of EIEE26. Treatment for EIEE26 typically involves antiepileptic medications and supportive therapies to manage symptoms and improve quality of life.